Orforglipron
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Eli Lilly · Phase 4 · Not yet recruiting · Enrollment 60
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Phentermine | Obesity or overweight | n/r | n/r | n/r | n/r |
| Orforglipron | Obesity or overweight | n/r | n/r | n/r | n/r |